Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGS 19755

Known as: CGS-19755 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Selfotel (CGS 19755), a competitivey N-methyl-D-aspartate antagonist, is neuroprotective in experimental models of ischemic… Expand
Is this relevant?
1996
1996
At 48 h following intrastriatal injection of N-methyl-D-aspartate (NMDA; 100 nmol/microliter) or endothelin-1 (ET-1; 143 pmol… Expand
Is this relevant?
1995
1995
Hypothermia or a glutamate receptor antagonist may offer protection when used before or within seconds of an ischemic insult. In… Expand
Is this relevant?
1995
1995
BACKGROUND AND PURPOSE CGS 19755 is a competitive N-methyl-D-aspartate (NMDA) receptor antagonist that limits neuronal damage in… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Neuronal injury induced by the excessive release of endogenous Zn2+ at central glutamatergic synapses may contribute to the… Expand
Is this relevant?
1991
1991
We report the effects of intravenous infusion of CGS-19755, a potent competitive N-methyl-D-aspartate (NMDA) antagonist, on local… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
1990
1990
We evaluated several doses of cis-4-(phosphonomethyl)-2-piperidine-carboxylic acid (CGS-19755), a potent competitive N-methyl-D… Expand
Is this relevant?
1989
1989
The purported competitive excitatory amino acid antagonist CGS 19755 was compared to the non-competitive antagonists ketamine and… Expand
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
1988
Highly Cited
1988
CGS 19755 (cis-4-phosphonomethyl-2-piperidine carboxylic acid) was found to be a potent, stereospecific inhibitor of N-methyl-D… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
N-Methyl-D-aspartate (NMDA) antagonists reduce ischemic brain damage and associated hypermotility. Two potent, selective and… Expand
Is this relevant?